Found 113 matching trials
Delayed Tolerance Through Mixed Chimerism PHASE1 This study will examine the safety and effectiveness of a bone marrow trans...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation PHASE1 This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Show More Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Learn More & Join Trial
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma NA This clinical trial studies peripheral blood hemapoietic stem cell mobiliza...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone PHASE1 This is a multi-site study with plerixafor in pediatric cancer patients. Th...
Show More Location
Investigational Site Number 51
Learn More & Join Trial
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma PHASE2 Background:
The mainstay of therapy for newly diagnosed multiple myeloma p...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL PHASE2 Mantle cell lymphoma (MCL) is a sub-type of non-Hodgkin's lymphoma (NHL) wh...
Show More Location
Stanford University Medical Center
Learn More & Join Trial
Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma PHASE2 The purpose of this study is to evaluate the effectiveness of Bortezomib wh...
Show More Location
H. Lee Moffitt Cancer Center
Learn More & Join Trial
G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients PHASE2 Primary Objectives:
1. To determine the efficacy of in vivo purging achiev...
Show More Location
U.T.M.D. Anderson Cancer Center
Learn More & Join Trial